share_log
Moomoo 24/7 ·  Apr 11 08:01
MEI Pharma Reports Initial Data From Clinical Study Evaluating Me-344 in Combination With Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment